Melanoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- The child must be under 2 years old.
- The child must have a medium, large, or giant congenital nevus (a type of birthmark present from birth) — either one or more — as classified by a specific medical system called the Krengel classification.
- The child must be covered by social security.
- The child's legal guardians or parents must agree to their child taking part in the study.
Who may not be able to join:
- Children who have light brown spots or pigmented skin marks that are not classified as nevi (birthmarks).
- Children for whom it would not be possible to attend regular yearly check-ups.
- Children whose parents do not speak French.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +33253482810
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Determine the prevalence of neurodevelopmental abnormalities in infants and young children with medium to giant congenital nevus, and according to nevus characteristics (size, number), at the age of 3 years.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.